NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $709,000 | -84.1% | 55,294 | -81.1% | 0.00% | -84.6% |
Q1 2022 | $4,450,000 | -13.9% | 291,801 | 0.0% | 0.03% | +4.0% |
Q4 2021 | $5,168,000 | -15.7% | 291,801 | 0.0% | 0.02% | -7.4% |
Q3 2021 | $6,134,000 | +6.6% | 291,801 | 0.0% | 0.03% | +8.0% |
Q2 2021 | $5,754,000 | -32.2% | 291,801 | 0.0% | 0.02% | -32.4% |
Q1 2021 | $8,483,000 | +162.6% | 291,801 | +173.7% | 0.04% | +208.3% |
Q4 2020 | $3,230,000 | +71.9% | 106,616 | -9.7% | 0.01% | +50.0% |
Q3 2020 | $1,879,000 | -23.5% | 118,100 | -5.1% | 0.01% | -27.3% |
Q2 2020 | $2,456,000 | -20.3% | 124,400 | -50.2% | 0.01% | -42.1% |
Q1 2020 | $3,083,000 | -33.3% | 250,000 | 0.0% | 0.02% | -24.0% |
Q4 2019 | $4,623,000 | +33.5% | 250,000 | 0.0% | 0.02% | +4.2% |
Q3 2019 | $3,463,000 | -5.4% | 250,000 | 0.0% | 0.02% | -4.0% |
Q2 2019 | $3,660,000 | – | 250,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $91,046,410 | 30.31% |
Euclidean Capital LLC | 746,674 | $3,748,303 | 3.51% |
StepStone Group LP | 1,573,357 | $7,898,252 | 1.03% |
EcoR1 Capital, LLC | 6,435,518 | $32,306,300 | 0.98% |
Rubric Capital Management LP | 877,161 | $4,403,348 | 0.19% |
Boxer Capital, LLC | 500,000 | $2,510,000 | 0.13% |
Jasper Ridge Partners, L.P. | 348,250 | $1,748,215 | 0.10% |
FOX RUN MANAGEMENT, L.L.C. | 45,798 | $229,906 | 0.09% |
PDT Partners, LLC | 104,383 | $524,003 | 0.08% |
GSA CAPITAL PARTNERS LLP | 129,279 | $649 | 0.08% |